242 results
S-8
EX-99.1
LSTA
Lisata Therapeutics Inc
17 Oct 22
Registration of securities for employees
4:02pm
as an Incentive Stock Option or to bring the Stock Award into compliance with Section 409A of the Code and Department of Treasury regulations and other … applicable, the Plan and Stock Award Agreements shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations
8-K/A
EX-99.2
5a2jelenman
4 Oct 22
Other Events
4:42pm
8-K
5rab9 gc0v7fq
29 Sep 22
Other Events
4:01pm
8-K
xh72bajooe
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
8-K
EX-99.3
lvnldk7p8h yy1m8n
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
gkekds7rl7d h7tc37nu
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-99.2
o1w1pqlhc59m5
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
rgpohdcffn
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-2.1
eagew1
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
i5u t9j2ct
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
7hl2ixlpv9w
18 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:47pm